NovaBay Pharmaceuticals I...

0.59
-0.02 (-2.48%)
At close: Mar 03, 2025, 12:10 PM

NovaBay Pharmaceuticals Ratios Statement

Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04 FY03
PE Ratio -0.09 -0.13 -2.23 -2.21 -1.22 -1.68 -7.97 n/a n/a n/a n/a -164.79 -237.7 -314.58 598.92 -93.77 -218.64 -136.97 -177.51 -197.8 -524.36
PEG Ratio 0.00 -0.00 0.04 0.06 -0.05 0.08 n/a n/a n/a n/a n/a -7.87 -34.79 1.24 -4.55 2.55 6.26 -4.63 -15.53 -1.2 n/a
PS Ratio 0.06 0.14 1.73 2.46 1.93 0.88 3.24 n/a n/a n/a n/a 166.68 109.69 138.94 102.99 113.18 199.67 472.30 n/a n/a n/a
PB Ratio 0.26 0.19 1.43 1.98 13.11 2.22 22.74 n/a n/a n/a n/a 82.42 129.36 129.19 121.04 103.58 82.45 399.36 189.03 n/a 638.77
P/FCF Ratio -0.21 -0.3 -1.58 -5.15 -1.6 -1.96 -9.06 n/a n/a n/a n/a -173.45 -370.66 742.59 -678.98 -72.1 -170.27 165.23 -183.34 n/a n/a
P/OCF Ratio -0.21 -0.31 -1.59 -5.18 -1.61 -1.97 -9.41 n/a n/a n/a n/a -177.38 -384.7 668.26 -980.15 -76.53 -188.27 152.62 -190.32 n/a n/a
OCF/S Ratio -0.28 -0.46 -1.09 -0.48 -1.2 -0.45 -0.34 -1.02 -4.24 -14.28 -3.73 -0.94 -0.29 0.21 -0.11 -1.48 -1.06 3.09 n/a n/a n/a
Debt / Equity Ratio 0.83 0.19 0.05 0.04 4.16 n/a n/a n/a -0.32 n/a n/a n/a n/a 0.01 0.04 0.12 0.06 n/a n/a n/a n/a
Quick Ratio 1.00 1.85 2.89 4.81 1.56 2.16 1.71 3.15 0.69 1.92 4.01 5.75 5.13 5.05 3.86 2.79 4.97 3.34 10.63 n/a n/a
Current Ratio 1.67 2.66 3.83 5.03 1.65 2.24 1.81 3.35 0.98 2.08 4.08 5.76 5.13 5.05 3.86 2.79 4.97 3.34 10.63 n/a n/a
Asset Turnover 1.63 0.88 0.35 0.65 0.59 1.34 1.81 0.77 0.86 0.14 0.22 0.36 0.69 0.63 0.90 0.48 0.25 0.13 n/a n/a n/a
Interest Coverage n/a n/a n/a n/a -8.93 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Return on Equity (ROE) -2.91 -1.54 -0.64 -0.9 -10.78 -1.32 -2.85 -1.85 3.72 -8.22 -1.88 -0.5 -0.54 -0.41 0.20 -1.1 -0.38 -2.92 -1.06 n/a -1.22
Return on Assets (ROA) -1.07 -0.99 -0.27 -0.72 -0.93 -0.7 -0.73 -0.86 -3.74 -2.02 -1.03 -0.37 -0.32 -0.28 0.15 -0.58 -0.23 -0.45 -0.97 n/a -0.74
Return on Capital (ROIC) -1.05 -0.63 -0.43 -0.52 -1.7 -1.43 -1.43 -0.99 -47.33 -4.03 -1.29 -0.52 -0.33 -0.35 0.20 -0.9 -0.3 -0.65 -1.1 n/a -0.72
Dividend Yield n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit Margin 53.61% 54.02% 67.03% 60.04% 73.66% 87.98% 84.73% 79.29% 71.22% 53.89% 95.34% 99.88% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% n/a n/a n/a
Net Profit Margin -65.46% -112.92% -77.89% -111.12% -158.92% -52.33% -40.61% -110.54% -433.07% -1.44K% -461.37% -101.15% -46.15% -44.17% 17.20% -120.71% -91.32% -344.81% n/a n/a n/a
Pretax Profit Margin -65.46% -73.65% -69.16% -111.07% -146.26% -52.29% -40.59% -110.52% -433.03% -1.44K% -461.32% -101.12% -46.13% -43.65% 17.24% -120.68% -91.12% -344.81% n/a n/a n/a
Operating Profit Margin -33.97% -53.32% -105.24% -64.69% -142.45% -62.93% -40.1% -92.31% -479.66% -1.6K% -445.38% -119.61% -39.21% -46.3% 17.47% -126.58% -99.37% -360.47% n/a n/a n/a
FCF Margin -28.18% -46.97% -109.77% -47.79% -120.44% -44.87% -35.73% -103.35% -426.43% -1.43K% -377.05% -96.1% -29.59% 18.71% -15.17% -156.98% -117.27% 285.84% n/a n/a n/a
EBITDA Margin -32.6% -49.97% -103.82% -64.17% -141.46% -60.8% -39.58% -91.35% -478.73% -1.58K% -436.35% -114.7% -35.36% -41.92% 20.08% -116.16% -88.03% -355.64% n/a n/a n/a